Bacteraemia after leadless pacemaker implantation
- 15 July 2020
- journal article
- research article
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 31 (9) , 2440-2447
Abstract
Background: Transvenous 3 permanent pacemaker‐related infection is a severe condition associated with significant morbidity and mortality. Leadless pacemakers may be more resistant to bacterial seeding during bloodstream infection because of its small surface area and encapsulation in the right ventricle. This study reports the incidence and outcomes of bacteraemia in patients implanted with a Micra leadless pacemaker. We present 18F‐fluorodeoxyglucose (FDG) positron emission tomography (PET)/computed tomography (CT) findings obtained in a subgroup of patients.Methods: We report a retrospective cohort study of 155 patients who underwent a Micra TPS implant procedure at the University Hospitals of Leuven between July 2015 and July 2019. We identified the patients who developed an episode of bacteraemia, proved by ≥2 positive blood cultures.Results: Of the 155 patients, 15 patients presented an episode of bacteraemia at a median of 226 days (range: 3–1129) days after the implant procedure. Gram‐positive species accounted for 73.3% (n = 11) of the bacteraemia including Staphylococcus (n = 5), Enterococcus (n = 3), and Streptococcus (n = 3). The source of infection was identified in nine patients (60%) including endocarditis in four patients, urinary tract in three patients, and skin in two patients. 18F‐FDG PET/CT imaging performed in six patients did not show sign of infection around the leadless pacemaker. Bacteraemia was resolved in all patients after adequate antibiotherapy. Four patients died early during follow up. For all other patients, there were no recurrence of systemic infection during a median follow up of 263 days (range: 15–1134).Conclusion: In our small cohort, no leadless pacemaker endocarditis was observed among patients with bacteraemia.Keywords
All Related Versions
This publication has 23 references indexed in Scilit:
- Incidence of device-related infection in 97 750 patients: clinical data from the complete Danish device-cohort (1982–2018)European Heart Journal, 2019
- 2018 EHRA expert consensus statement on lead extraction: recommendations on definitions, endpoints, research trial design, and data collection requirements for clinical scientific studies and registries: endorsed by APHRS/HRS/LAHRSEP Europace, 2018
- 2017 HRS expert consensus statement on cardiovascular implantable electronic device lead management and extractionHeart Rhythm, 2017
- The Risk of Cardiac Device-Related Infection in Bacteremic Patients Is Species Specific: Results of a 12-Year Prospective CohortOpen Forum Infectious Diseases, 2017
- 2015 ESC Guidelines for the management of infective endocarditisEuropean Heart Journal, 2015
- Role of 18F-FDG PET/CT in the diagnosis of infective endocarditis in patients with an implanted cardiac device: a prospective studyEuropean Journal of Nuclear Medicine and Molecular Imaging, 2014
- Usefulness of Fluorine-18 Positron Emission Tomography/Computed Tomography for Identification of Cardiovascular Implantable Electronic Device InfectionsJACC, 2012
- Whole body [18F]fluorodeoxyglucose positron emission tomography imaging for the diagnosis of pacemaker or implantable cardioverter defibrillator infection: a preliminary prospective studyClinical Microbiology and Infection, 2011
- Complication Rates Associated With Pacemaker or Implantable Cardioverter-Defibrillator Generator Replacements and Upgrade ProceduresCirculation, 2010
- Staphylococcus aureus Bacteremia in Patients With Permanent Pacemakers or Implantable Cardioverter-Defibrillators Circulation, 2001